Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer, Sanford-Burnham Team Up on Obesity, Diabetes Target Research
GenEngNews
Wednesday, August 14, 2013 - 10:23am
tags:
Pfizer, Sanford-Burnham Medical Research Institute, R&D, obesity, diabetes
Novartis to Review Business as Reinhardt Becomes Chairman, Would Consider a $10 Billion Purchase
Bloomberg
Wednesday, August 14, 2013 - 10:21am
tags:
Novartis, Joerg Reinhardt, M&A
Novartis, Pfizer Said to Be Out of Bidding for Onyx
Bloomberg
Wednesday, August 14, 2013 - 10:19am
tags:
Novartis, Pfizer, ONYX Pharmaceuticals, Amgen, M&A
Receptos Could Meet With A More Positive Reception
Seeking Alpha
Wednesday, August 14, 2013 - 10:16am
tags:
Receptos, Novartis, Gilenya, MS, multiple sclerosis, RPC1063
China to launch fresh pharmaceutical bribery probe
Yahoo/Reuters
Wednesday, August 14, 2013 - 9:32am
tags:
China, Novartis
MannKind's inhaled insulin Afrezza meets goals in 2 late-stage studies of diabetes patients
Yahoo/AP
Wednesday, August 14, 2013 - 9:17am
tags:
insulin, diabetes MannKind, Afrezza, inhaled insulin
Merck rolls out new training program for Zilmax customers
Reuters
Wednesday, August 14, 2013 - 9:16am
tags:
Merck, Zilmax, animal health
FDA Delivers a Double Dose of Good News in the Fight Against HIV
Motley Fool
Wednesday, August 14, 2013 - 9:15am
tags:
FDA, HIV, Alere, Alere Determine, Tivicay, vaccines, ViiV Healthcare, GSK, Shionogi, Pfizer
Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
Yahoo/Street Authority
Wednesday, August 14, 2013 - 9:13am
tags:
lung cancer, Eli Lilly, necitumumab, non-small cell lung cancer
[video]Time to Panic About Pfizer's Upcoming Patent Expirations?
Motley Fool
Wednesday, August 14, 2013 - 9:11am
tags:
patents, Pfizer
2 Biotechs Aim To Capitalize On The Treatment Of Melanoma
Seeking Alpha
Tuesday, August 13, 2013 - 4:13pm
tags:
melanoma, Amgen, OncoSec, Vical, TVEC, NeoPulse
Osiris shares rocket, company details Grafix study
Yahoo/AP
Tuesday, August 13, 2013 - 4:09pm
tags:
Grafix, Osiris Therapeutics, diabetes, diabetic foot ulcers
Report: Novartis Bails on Onyx Bid
Barron's
Tuesday, August 13, 2013 - 4:06pm
tags:
Novartis, ONYX Pharmaceuticals, M&A
The Next Big Opportunity in Antidepressant Drugs
Motley Fool
Tuesday, August 13, 2013 - 11:08am
tags:
antidepressants, Pfizer, Eli Lilly, Forest Labs, Cymbalta, Fetzima, Pristiq, major depressive disorder
Is This Biotech Stock Worth Buying After a Massive Post-IPO Surge?
Motley Fool
Tuesday, August 13, 2013 - 11:06am
tags:
IPOs, Intrexon, Eli Lilly, synthetic DNA
Acasti announces positive phase 2 open label clinical trial result
The Fly on the Wall
Tuesday, August 13, 2013 - 11:04am
tags:
Acasti, clinical trials, CaPre, hypertriglyceridemia
ZS Associates: What do pharma reps need to get face time with doctors?
Fierce Pharma
Tuesday, August 13, 2013 - 11:03am
tags:
physicians, drug reps
LAT: Purdue keeps 'risky' OxyContin prescribers' names private
Fierce Pharma
Tuesday, August 13, 2013 - 11:01am
tags:
Purdue Pharma, physicians, oxycontin
Between RX and A Hard Place: Biotechs Flash Warnings
Investors.com
Tuesday, August 13, 2013 - 11:00am
tags:
Alexion, BiogenIdec, Santarus, Regeneron
Biota Pharma's Game-Changer, Laninamivir: Are You Ready For The Next Pandemic Flu?
Seeking Alpha
Tuesday, August 13, 2013 - 10:56am
tags:
Biota, Laninamivir, Flu, antivirals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.